Treatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infection

被引:34
作者
Kuster, H [1 ]
Opravil, M
Ott, P
Schlaepfer, E
Fischer, M
Günthard, HF
Lüthy, R
Weber, R
Cone, RW
机构
[1] Univ Zurich Hosp, Div Infect Dis, Dept Internal Med, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Policlin Ear Nose Throat & Face Surg, CH-8091 Zurich, Switzerland
关键词
D O I
10.1016/S0002-9440(10)65070-5
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We report detailed quantitative analysis of human immunodeficiency virus-1 (HIV-1) p24 and HIV-1 RNA in tonsil biopsies from 13 patients with early, asymptomatic HIV infection before and during combination antiretroviral therapy. Using fluorescent microscopy in conjunction with reverse transcriptase-polymerase chain reaction of frozen tissue sections, we show that plasma and tissue viral loads decreased by approximately 3 logs during the 1-year treatment period, with good correlation between the HIV-1 p24 and HIV-1 RNA response in tissue. The decrease of tissue viral load was delayed compared to plasma viral load, possibly explained by the observation that the amount of follicular dendritic cell-associated virus correlated best with the area under the curve of plasma HIV-1 RNA throughout the last 12 weeks. Before and during treatment, the relative proportions of HIV-1 on follicular dendritic cells and within mononuclear cells remained constant, suggesting similar decay characteristics in these two lymphoid tissue compartments. However, viral p24 or RNA remained almost always detectable in tissue despite full suppression of HIV-1 RNA in plasma, and increased even after short-term rebounds in plasma viral load. Thus, full and sustained suppression of viral replication was required to efficiently decrease viral load in lymphoid tissue, but complete abolition of residual viral replication was not achieved.
引用
收藏
页码:1973 / 1986
页数:14
相关论文
共 45 条
[1]   Early reduction of immune activation in lymphoid tissue following highly active HIV therapy [J].
Andersson, J ;
Fehniger, TE ;
Patterson, BK ;
Pottage, J ;
Agnoli, M ;
Jones, P ;
Behbahani, H ;
Landay, A .
AIDS, 1998, 12 (11) :F123-F129
[2]  
BARONI CD, 1988, AM J PATHOL, V133, P498
[3]  
BIBERFELD P, 1986, AM J PATHOL, V125, P436
[4]   Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities [J].
Bisset, LR ;
Cone, RW ;
Huber, W ;
Battegay, M ;
Vernazza, PL ;
Weber, R ;
Grob, PJ ;
Opravil, M .
AIDS, 1998, 12 (16) :2115-2123
[5]   Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection [J].
Cavert, W ;
Notermans, DW ;
Staskus, K ;
Wietgrefe, SW ;
Zupancic, M ;
Gebhard, K ;
Henry, K ;
Zhang, ZQ ;
Mills, R ;
McDade, H ;
Goudsmit, J ;
Danner, SA ;
Haase, AT .
SCIENCE, 1997, 276 (5314) :960-964
[6]   Studies on lymphoid tissue from HIV-infected individuals: Implications for the design of therapeutic strategies [J].
Cohen, OJ ;
Pantaleo, G ;
Lam, GK ;
Fauci, AS .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1997, 18 (03) :305-322
[7]  
DIRKS RW, 1993, J CELL SCI, V104, P1187
[8]   Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy [J].
Dornadula, G ;
Zhang, H ;
VanUitert, B ;
Stern, J ;
Livornese, L ;
Ingerman, MJ ;
Witek, J ;
Kedanis, RJ ;
Natkin, J ;
DeSimone, J ;
Pomerantz, RJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (17) :1627-1632
[9]   Highly sensitive methods for quantitation of human immunodeficiency virus type 1 RNA from plasma, cells, and tissues [J].
Fischer, M ;
Huber, W ;
Kallivroussis, A ;
Ott, P ;
Opravil, M ;
Lüthy, R ;
Weber, R ;
Cone, RW .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (05) :1260-1264
[10]   LYMPHOID GERMINAL-CENTERS ARE RESERVOIRS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA [J].
FOX, CH ;
TENNERRACZ, K ;
RACZ, P ;
FIRPO, A ;
PIZZO, PA ;
FAUCI, AS .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (06) :1051-1057